Uncategorized

News Recap: NTN Buzztime, Inc. (NYSE:NTN) & Applied Genetic Technologies Corporation (NASDAQ:AGTC)

NTN Buzztime, Inc. (NYSE:NTN)

NTN Buzztime, Inc.is a leading developer, publisher and distributor of interactive entertainment for massive audiences on numerous consumer platforms. Millions of people are exposed to the Buzztime Network every month in restaurants, sports bars and pubs throughout the U.S., Canada and the UK. Originating from the Buzztime iTV Studio in Carlsbad, CA for over 20 years, the Network includes trivia game shows, card games, live sports games, polling and other games that enable a virtually unlimited number of people to play live competitions against one another for fun, prizes and fame. Buzztime’s programming is also available on cable TV, satellite TV, mobile phones, electronic home games, portable travel games and as a trivia book series. The Company also owns and operates NTN Hospitality Technologies which develops, sells and services software and technology that increase productivity and sales in casual dining restaurants.

NTN Buzztime, Inc. (NYSE:NTN)’s Financial Overview

NTN Buzztime, Inc. (NYSE) declined -0.29% yesterday to close its trading session at $3.45. The company has 1 year Price Target of $5.5. NTN Buzztime, Inc. has 52-Week high of $8.4 and 52-Week Low of $1.8. The stock touched its 52-Week High on 8.40 and 52-Week Low on 1.80. The stock traded with the volume of 100448 shares yesterday. The firm shows the market capitalization of $9.69 Million.

NTN Buzztime, Inc. (NYSE) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $0.08/share against the analyst consensus estimate of $-0.04/share. The difference between the actual and expected EPS is $0.12 a share with a surprise factor of 300%.

The firm is trading with SMA20 of 57.21 Percent, SMA50 of 37.83 Percent and SMA200 of -17.34 percent. NTN Buzztime, Inc. has P/S value of 0.43 while its P/B value stands at 1.43. Similarly, the company has Return on Assets of -5.9 percent, Return on Equity of -15.7 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 65.8 percent and -1.6 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 1 analysts offering 12-month price forecasts for NTN Buzztime Inc have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate represents a +59.42% increase from the last price of 3.45.

NTN Buzztime, Inc. is estimated to report earnings on 03/05/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.15. The reported EPS for the same quarter last year was $-0.25.

Applied Genetic Technologies Corporation (NASDAQ:AGTC)

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan ophthalmology diseases. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. Applied Genetic Technologies Corporation is headquartered in Alachua, Florida.

Applied Genetic Technologies Corporation (NASDAQ:AGTC)’s Financial Outlook

The 5 analysts offering 12-month price forecasts for Applied Genetic Technologies Corp have a median target of 5.75, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +91.67% increase from the last price of 3.00.

Applied Genetic Technologies Corporation is estimated to report earnings on 02/08/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.64. The reported EPS for the same quarter last year was $-0.29.

According to Zacks Investment Research, Applied Genetic Technologies Corporation has a Consensus Recommendation of 1.8. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock declined -1.32% and closed its last trading session at $3. The company has the market capitalization of $53.52 Million. The stock has 52-week high of $7.5 and 52-Week low of $2.26. The firm touched its 52-Week high on 7.50 and 52-Week low on 2.26. The company has volume of 42771 shares. The company has a total of 17.84 Million shares outstanding.

Applied Genetic Technologies Corporation (NASDAQ) in the last quarter reported its actual EPS of $0.07/share where the analyst estimated EPS was $-0.39/share. The difference between the actual and Estimated EPS is $0.46. This shows a surprise factor of 117.9 percent.

The company has YTD performance of 20.48 percent. Beta for Applied Genetic Technologies Corporation stands at 2.86 while its ATR (average true range) is 0.34. The company has Weekly Volatility of 5.27%% and Monthly Volatility of 9.00%%.

Applied Genetic Technologies Corporation has distance from 20-day Simple Moving Average (SMA20) of 7.68%, Distance from 50-Day Simple Moving Average of -38.53 percent and Distance from 200-Day Simple Moving Average of -38.13%.

The Company currently has ROA (Return on Assets) of -15.2 percent, Return on Equity (ROE) of -19 Percent and Return on Investment (ROI) of -23.4% with Gross margin of 0 percent and Operating & Profit margin of -71.5% and -67% respectively.